-
Welcome to the Anaphylaxis Campaign
Resources and information for healthcare professionals
-
Welcome to the Anaphylaxis Campaign
Resources and information for healthcare professionals
Explore our website
Donate today
Please donate today to help us provide free services for people in need of advice and support
Related products
Healthcare News
MHRA issues Emerade Alert Update
28th November 2019
Thursday 28th November 2019 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received reports of Emerade pens failing to activate. This means that in some cases, the needle is not released, and the injection of adrenaline is not delivered. This alert is an update to the previous drug alert issued […]
Read More...
EpiPen 0.3mg Auto-Injectors have Longer Shelf Life
15th November 2019
EpiPen 0.3mg auto-injector devices have now had their shelf life increased from 20 months to 24 months from the date of manufacture. Expiry dates can be found on the label on the auto-injector device and should not be used after this date. The shelf life for EpiPen 0.15mg auto-injector devices remains at 19 months from […]
Read More...
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma.
25th October 2019
Abstract To fully understand the role of diet diversity on allergy outcomes and to set standards for conducting research in this field, the European Academy of Allergy and Clinical Immunology Task Force on Diet and Immunomodulation has systematically explored the association between diet diversity and allergy outcomes. In addition, a detailed narrative review of information […]
Read More...
Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens
25th October 2019
Abstract Background Food allergies are a significant public health issue, and the only effective management option currently available is strict avoidance of all foods containing the allergen. In view of the practical impossibility of limiting risks to zero, quantitative allergen risk assessment and management strategies are needed. Objective We sought to develop appropriate methods for […]
Read More...